Cite
Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation.
MLA
Mahadeo, Kris M., et al. “Durable Engraftment and Correction of Hematological Abnormalities in Children with Congenital Amegakaryocytic Thrombocytopenia Following Myeloablative Umbilical Cord Blood Transplantation.” Pediatric Transplantation, vol. 19, no. 7, Nov. 2015, pp. 753–57. EBSCOhost, https://doi.org/10.1111/petr.12577.
APA
Mahadeo, K. M., Tewari, P., Parikh, S. H., Driscoll, T. A., Page, K., Martin, P. L., Kurtzberg, J., & Prasad, V. K. (2015). Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation. Pediatric Transplantation, 19(7), 753–757. https://doi.org/10.1111/petr.12577
Chicago
Mahadeo, Kris M., Priti Tewari, Suhag H. Parikh, Timothy A. Driscoll, Kristin Page, Paul L. Martin, Joanne Kurtzberg, and Vinod K. Prasad. 2015. “Durable Engraftment and Correction of Hematological Abnormalities in Children with Congenital Amegakaryocytic Thrombocytopenia Following Myeloablative Umbilical Cord Blood Transplantation.” Pediatric Transplantation 19 (7): 753–57. doi:10.1111/petr.12577.